Is Doximity, Inc. (DOCS) Overvalued?
We dive into why Doximity, Inc. (DOCS) could be considered overvalued on 2026-07-30, based on AAII’s Value Score and Grade.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Commentary & Analysis
Why Doximity, Inc.’s (DOCS) Stock Is Up 6.73%
As of Wednesday, July 01, Doximity, Inc.’s DOCS share price has surged by 6.73%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Doximity, Inc.’s (DOCS) Stock Is Up 8.94%
As of Friday, May 15, Doximity, Inc.’s DOCS share price has surged by 8.94%, which has investors questioning if this is right time to sell.Michael Rose
Why Doximity, Inc.’s (DOCS) Stock Is Down 23.39%
As of Thursday, May 14, Doximity, Inc.’s DOCS share price has dipped by 23.39%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Doximity, Inc.’s (DOCS) Stock Is Down 23.94%
As of Thursday, May 14, Doximity, Inc.’s DOCS share price has dipped by 23.94%, which has investors questioning if this is right time to buy.Tudor Pop
Financial Summary
| Share Statistics | DOCS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3,758.6 | $179.6 | 63% |
|
| Shares Out (Mil) | 195.0 | 47.9 | 76% |
|
| Institutional Ownership | 71.7% | 78.6% | 44% |
|
| Float (Mil) | 125.2 | 40.1 | 66% |
|
| Beta | 1.35 | 1.22 | 78% |
|
| Avg Daily Volume (000s) | 3,273 | 205 | 88% |
|
| Price Change (52-week) |
(64.5%) | 41.0% | 11% |
|
| Growth | DOCS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 25.5% | 13.7% | 87% |
|
| Net Income (5yr) | 31.3% | (1.0%) | 85% |
|
| EPS (5yr) | 33.6% | 15.5% | 84 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (26.9%) | (15.5%) | 23% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 18 | 18 | 15 | |
| Current EPS | $0.303 | $1.433 | $1.594 | |
| Month Ago EPS | $0.303 | $1.434 | $1.594 | |
| # Rev Up | 2 | 1 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | $0.345 | $1.621 | $1.788 | |
| Year/Year Chg | 215.6% | 46.2% | 86.2% | |
| Financials | DOCS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $645 | $192 | 45% |
|
| Net Income (TTM) (Mil) | $196 | ($9) | 68% |
|
| EPS (TTM) | $1.048 | ($0.500) | 61% |
|
| Operating Cash Flow (TTM) (Mil) | $327 | $8 | 66% |
|
| Net Cash Flow (TTM) (Mil) | $10 | ($3) | 57% |
|
| Long-Term Debt (Q1) (Mil) | $8 | $14 | 27% |
|
| Enterprise Value (Q1) (Mil) | $2,893 | $215 | 54% |
|
| Valuation | DOCS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.03 | 1.22 | 73% |
|
| P/E | 21.3 | 36.1 | 54% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.6 | 2.0 | 31% |
|
| Ratios | DOCS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 89.1% | 61.6% | 93% |
|
| Net Margin | 30.4% | (29.3%) | 89% |
|
| ROA | 16.4% | (21.9%) | 94% |
|
| ROE | 19.3% | (1.4%) | 79% |
|
| Liabilities to Assets | 15.4% | 33.3% | 9% |
|
| F-Score | 6 | 4 | 69% |
|
Doximity, Inc. did not pass any screens on 7/31/2026.
